-transparent.png){kind=logo}
Haloperidol is extracted with hexane-isoamyl alcohol in the presence of two internal standards, chlorohaloperidol and spiroperidol. For chromatographic separation, a C18 reversed-phase column and a mobile phase of acetonitrile/methanol/phosphate buffer are used. Detection is by UV absorption spectrophotometry at 245 nm, and the limit of detection was set to 1 ng/ml. To study hydroxyhaloperidol, a metabolite of haloperidol which has much less UV-absorption than haloperidol, detection must be seat 220 nm.
Related Publications
D Hequet, and
C Jarry, and
C Rouquette, and
A Brachet-Liermain
January 1990,
Annales de biologie clinique,
D Hequet, and
C Jarry, and
C Rouquette, and
A Brachet-Liermain
July 1986,
Journal of chromatography,
D Hequet, and
C Jarry, and
C Rouquette, and
A Brachet-Liermain
January 1983,
Therapeutic drug monitoring,
D Hequet, and
C Jarry, and
C Rouquette, and
A Brachet-Liermain
October 1987,
Clinical chemistry,
D Hequet, and
C Jarry, and
C Rouquette, and
A Brachet-Liermain
September 1976,
Journal of pharmaceutical sciences,
D Hequet, and
C Jarry, and
C Rouquette, and
A Brachet-Liermain
January 1982,
Annales de biologie clinique,
D Hequet, and
C Jarry, and
C Rouquette, and
A Brachet-Liermain
March 1978,
Journal of chromatography,
D Hequet, and
C Jarry, and
C Rouquette, and
A Brachet-Liermain
November 1990,
Therapeutic drug monitoring,
D Hequet, and
C Jarry, and
C Rouquette, and
A Brachet-Liermain
June 1988,
Journal of pharmaceutical sciences,
D Hequet, and
C Jarry, and
C Rouquette, and
A Brachet-Liermain
April 1997,
Therapeutic drug monitoring,
